DJIA 16,374.76 23.38 0.14%
NASDAQ 4,733.50 -16.48 -0.35%
S&P 500 1,951.13 2.27 0.12%
market minute promo

58.75 -0.86 (-1.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BMY $58.75 -1.44%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $60.42
Previous Close $59.61
Daily Range $58.61 - $60.97
52-Week Range $47.55 - $70.54
Market Cap $98.0B
P/E Ratio 55.71
Dividend (Yield) $1.48 (2.5%)
Ex-Dividend Date
Dividend Pay Date
07/01/15
08/03/15
Volume 8,230,213
Average Daily Volume 6,723,235
Current FY EPS $1.81

Sector

Healthcare

Industry

Drug Makers

Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website: http://www.bms.com/

News & Commentary

New Skin Cancer Drugs Delayed (but Investors and Patients Needn't Worry)

FDA decisions for Bristol-Myers Sqibb's Opdivo and Merck's Keytruda get pushed back.

Bristol-Myers' (BMY) Opdivo Gets Priority Review, Shares Up

Why It's Worth Watching Donald Trump's Stock Portfolio

BMY October 23rd Options Begin Trading

Bristol-Myers/AbbVie Cancer Drug Gets Priority Review

Bristol-Myers Squibb to Host Investor Teleconference to Discuss World Conference on Lung Cancer (WCL

Bristol-Myers Squibb to Host Investor Teleconference to Discuss World Conference on Lung Cancer (WCLC) Highlights

Bristol-Myers Squibb (BMY) Stock Climbs on FDA Acceptance for Expanded Opdivo Drug Use

U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (niv

U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Non-Squamous Non-Small Cell Lung Cancer Patients

Bristol-Myers to Pay up to $1.25B for Right to Buy Promedior

Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval?

VHT, MRK, BMY, LLY: Large Outflows Detected at ETF

See More BMY News...

BMY's Top Competitors

BMY $58.75 (-1.44%)
Current stock: BMY
JNJ $92.64 (-0.76%)
Current stock: JNJ
NVS $95.36 (-0.25%)
Current stock: NVS
RHHBY $33.40 (0.24%)
Current stock: RHHBY